350 related articles for article (PubMed ID: 36149151)
1. Exploring quality of life among head-and-neck cancer patients in Western India using European organization for research and treatment of cancer questionnaires.
Parkar S; Sharma A; Shah M
J Cancer Res Ther; 2022; 18(4):990-996. PubMed ID: 36149151
[TBL] [Abstract][Full Text] [Related]
2. Psychometric properties of the Urdu version of the EORTC QLQ-H&N35 (European organization for research and treatment of cancer head and neck module) quality of life tool.
Zahid N; Martins RS; Zahid W; Azam I; Ikram M; Hassan A; Bhamani SS; Jabbar AA; Asad N; Akhtar S; Siddiqui MI; Awan MS; Ahmad K
BMC Psychol; 2022 Aug; 10(1):194. PubMed ID: 35934706
[TBL] [Abstract][Full Text] [Related]
3. Identifying cutoff scores for the EORTC QLQ-C30 and the head and neck cancer-specific module EORTC QLQ-H&N35 representing unmet supportive care needs in patients with head and neck cancer.
Jansen F; Snyder CF; Leemans CR; Verdonck-de Leeuw IM
Head Neck; 2016 Apr; 38 Suppl 1():E1493-500. PubMed ID: 27111696
[TBL] [Abstract][Full Text] [Related]
4. A 12 country field study of the EORTC QLQ-C30 (version 3.0) and the head and neck cancer specific module (EORTC QLQ-H&N35) in head and neck patients. EORTC Quality of Life Group.
Bjordal K; de Graeff A; Fayers PM; Hammerlid E; van Pottelsberghe C; Curran D; Ahlner-Elmqvist M; Maher EJ; Meyza JW; Brédart A; Söderholm AL; Arraras JJ; Feine JS; Abendstein H; Morton RP; Pignon T; Huguenin P; Bottomly A; Kaasa S
Eur J Cancer; 2000 Sep; 36(14):1796-807. PubMed ID: 10974628
[TBL] [Abstract][Full Text] [Related]
5. Pembrolizumab alone or with chemotherapy for recurrent or metastatic head and neck squamous cell carcinoma: Health-related quality-of-life results from KEYNOTE-048.
Rischin D; Harrington KJ; Greil R; Soulières D; Tahara M; de Castro G; Psyrri A; Braña I; Neupane P; Bratland Å; Fuereder T; Hughes BGM; Mesía R; Ngamphaiboon N; Rordorf T; Ishak WZW; Hong RL; Mendoza RG; Jia L; Chirovsky D; Norquist J; Jin F; Burtness B
Oral Oncol; 2022 May; 128():105815. PubMed ID: 35381576
[TBL] [Abstract][Full Text] [Related]
6. Assessing quality of life in patients with head and neck cancer: cross-validation of the European Organization for Research and Treatment of Cancer (EORTC) Quality of Life Head and Neck module (QLQ-H&N35).
Sherman AC; Simonton S; Adams DC; Vural E; Owens B; Hanna E
Arch Otolaryngol Head Neck Surg; 2000 Apr; 126(4):459-67. PubMed ID: 10772298
[TBL] [Abstract][Full Text] [Related]
7. Health-related quality of life in 640 head and neck cancer survivors after radiotherapy using EORTC QLQ-C30 and QLQ-H&N35 questionnaires.
Wan Leung S; Lee TF; Chien CY; Chao PJ; Tsai WL; Fang FM
BMC Cancer; 2011 Apr; 11():128. PubMed ID: 21486431
[TBL] [Abstract][Full Text] [Related]
8. Validation of Gujarati Version of European Organization for Research and Treatment of Cancer Quality of Life Modules in Head and Neck Cancer Patients of Western India.
Parkar S; Sharma A; Shah M
Indian J Otolaryngol Head Neck Surg; 2022 Oct; 74(Suppl 2):2291-2301. PubMed ID: 36452740
[TBL] [Abstract][Full Text] [Related]
9. Quality of life of head and neck cancer patients before and after cancer-directed treatment - A longitudinal study.
Bashir A; Kumar D; Dewan D; Sharma R
J Cancer Res Ther; 2020; 16(3):500-507. PubMed ID: 32719257
[TBL] [Abstract][Full Text] [Related]
10. A preliminary study on the relationships between global health/quality of life and specific head and neck cancer quality of life domains in Puerto Rico.
Psoter WJ; Aguilar ML; Levy A; Baek LS; Morse DE
J Prosthodont; 2012 Aug; 21(6):460-71. PubMed ID: 22469330
[TBL] [Abstract][Full Text] [Related]
11. Quality of life in head and neck cancer patients: validation of the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-H&N35.
Bjordal K; Hammerlid E; Ahlner-Elmqvist M; de Graeff A; Boysen M; Evensen JF; Biörklund A; de Leeuw JR; Fayers PM; Jannert M; Westin T; Kaasa S
J Clin Oncol; 1999 Mar; 17(3):1008-19. PubMed ID: 10071296
[TBL] [Abstract][Full Text] [Related]
12. Quality of life of head and neck cancer patient: validation of the European organization for research and treatment of cancer QLQ-C30 and European organization for research and treatment of cancer QLQ-H&N 35 in Indian patients.
Chaukar DA; Das AK; Deshpande MS; Pai PS; Pathak KA; Chaturvedi P; Kakade AC; Hawaldar RW; D'Cruz AK
Indian J Cancer; 2005; 42(4):178-84. PubMed ID: 16391435
[TBL] [Abstract][Full Text] [Related]
13. Validation of the Mexican Spanish version of the EORTC QLQ-H&N35 instrument to measure health-related quality of life in patients with head and neck cancers.
Carrillo JF; Ortiz-Toledo MA; Salido-Noriega Z; Romero-Ventura NB; Ochoa-Carrillo FJ; Oñate-Ocaña LF
Ann Surg Oncol; 2013 May; 20(5):1417-26. PubMed ID: 23108555
[TBL] [Abstract][Full Text] [Related]
14. Quality of life among total laryngectomized patients undergoing speech rehabilitation: correlation between several instruments.
Raquel ACS; Buzaneli EP; Silveira HSL; Simões-Zenari M; Kulcsar MAV; Kowalski LP; Nemr K
Clinics (Sao Paulo); 2020; 75():e2035. PubMed ID: 33206762
[TBL] [Abstract][Full Text] [Related]
15. Nivolumab versus standard, single-agent therapy of investigator's choice in recurrent or metastatic squamous cell carcinoma of the head and neck (CheckMate 141): health-related quality-of-life results from a randomised, phase 3 trial.
Harrington KJ; Ferris RL; Blumenschein G; Colevas AD; Fayette J; Licitra L; Kasper S; Even C; Vokes EE; Worden F; Saba NF; Kiyota N; Haddad R; Tahara M; Grünwald V; Shaw JW; Monga M; Lynch M; Taylor F; DeRosa M; Morrissey L; Cocks K; Gillison ML; Guigay J
Lancet Oncol; 2017 Aug; 18(8):1104-1115. PubMed ID: 28651929
[TBL] [Abstract][Full Text] [Related]
16. Assessing the Comparability of Paper and Electronic Versions of the EORTC QOL Module for Head and Neck Cancer: A Qualitative Study.
Norquist J; Chirovsky D; Munshi T; Tolley C; Panter C; Gater A
JMIR Cancer; 2017 May; 3(1):e7. PubMed ID: 28500019
[TBL] [Abstract][Full Text] [Related]
17. Mapping the EORTC QLQ-C30 and QLQ-H&N35 to the EQ-5D for head and neck cancer: Can disease-specific utilities be obtained?
Beck ACC; Kieffer JM; Retèl VP; van Overveld LFJ; Takes RP; van den Brekel MWM; van Harten WH; Stuiver MM
PLoS One; 2019; 14(12):e0226077. PubMed ID: 31834892
[TBL] [Abstract][Full Text] [Related]
18. [The European Organisation for Research and Treatment of Cancer (EORTC) Quality of Life Questionnaire for Japanese patients with head and neck cancer--the Japanese version of QLQ-H&N35].
Toth G; Tsukuda M
Gan To Kagaku Ryoho; 2004 Mar; 31(3):461-7. PubMed ID: 15045963
[TBL] [Abstract][Full Text] [Related]
19. Early quality of life outcomes after surgery in head and neck cancer survivors with EORTC QLQ-C30 and EORTC QLQ-HN35 in an Asian tertiary centre.
Kao NH; Iyer NG; Chua A; Nagadia RH
Support Care Cancer; 2022 May; 30(5):4537-4546. PubMed ID: 35119518
[TBL] [Abstract][Full Text] [Related]
20. Increased Pain Reporting by Head and Neck Cancer Patients at Radiation Oncology Consultation: A Quality-of-Life Analysis.
Havard M; Esslinger H; Mierzwa M; Kharofa J; Takiar V
Laryngoscope; 2021 Feb; 131(2):326-332. PubMed ID: 32609888
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
